Top compounds associated with response to PELO


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0024 1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.002 1
mRNA 1S,3R-RSL-3 CTRPv2 pan-cancer AAC 0.0019 1
mRNA BRD-K52037352 CTRPv2 pan-cancer AAC -0.0021 1
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.0025 1
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC -0.0017 1
mRNA ML320 CTRPv2 pan-cancer AAC 0.0016 1
mRNA KU-0063794 CTRPv2 pan-cancer AAC 0.0015 1
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC -0.0029 1
mRNA MK 1775 CTRPv2 pan-cancer AAC -0.0011 1
Download CSV